Status:
COMPLETED
Myocardial Injury and Major Adverse Outcomes in Patients With COVID-19
Lead Sponsor:
Icahn School of Medicine at Mount Sinai
Conditions:
COVID-19
Myocardial Reperfusion Injury
Eligibility:
All Genders
Brief Summary
The study will analyze the incidence, clinical outcomes and predictors of myocardial injury in a large patient population with COVID-19 treated in Mount Sinai Hospital (MSH) system. In addition, the s...
Detailed Description
The study team's understanding of diagnosis, treatment and outcomes of coronavirus disease 2019 (COVID-19) is rapidly evolving. First reports from China clearly indicate that older patients with under...
Eligibility Criteria
Inclusion
- Laboratory confirmed COVID-19
Exclusion
- None
Key Trial Info
Start Date :
May 8 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2022
Estimated Enrollment :
4695 Patients enrolled
Trial Details
Trial ID
NCT04397939
Start Date
May 8 2020
End Date
March 1 2022
Last Update
March 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mount Sinai Hospital
New York, New York, United States, 10029